GO:0048385 regulation of retinoic acid receptor signaling pathway: Mechanism, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0048385 describes any process that modulates the frequency, rate or extent of retinoic acid receptor (RAR) signaling pathway activity.
RAR signaling is evolutionarily conserved and controls gene expression in development, differentiation, and tissue homeostasis.
Regulation occurs at multiple levels, including ligand availability, receptor expression, cofactor recruitment, and post-translational modifications.
Dysregulation of RAR signaling is implicated in cancers, neuropathic pain, male germ cell differentiation defects, and developmental disorders.
Key experimental models include knockout, point-mutation, knock-in, and overexpression cell lines, as well as CRISPR library screening.
Studying GO:0048385 requires integrating transcriptomics, proteomics, and imaging to capture dynamic regulatory events.

Description

The Gene Ontology term GO:0048385, regulation of retinoic acid receptor signaling pathway, encompasses any process that modulates the frequency, rate or extent of retinoic acid receptor (RAR) signaling activity. RAR signaling is a conserved metazoan pathway that translates retinoic acid (RA) gradients into transcriptional programs controlling development, differentiation, and homeostasis. Because RAR signaling is tightly regulated, its modulation is critical for normal physiology and is frequently altered in disease. Researchers study GO:0048385 to understand how cells integrate RA signals and to identify therapeutic targets. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of the mechanisms, genes, and methods used to investigate this regulatory process.

regulation of retinoic acid receptor signaling pathway At A Glance

GO ID GO:0048385
GO term regulation of retinoic acid receptor signaling pathway
Ontology biological_process
Synonym regulation of RAR signaling pathway; regulation of retinoic acid receptor signalling pathway
Major function Modulates the frequency, rate or extent of RAR signaling pathway activity
Related pathway Retinoic acid receptor signaling
Key ligands Retinoic acid (all-trans and 9-cis RA)
Key receptors RAR alpha, beta, gamma; RXR alpha, beta, gamma
Cellular context Nucleus, cytoplasm, and membrane-associated signaling complexes

What Is GO:0048385?

GO:0048385 is defined as any process that modulates the frequency, rate or extent of retinoic acid receptor signaling pathway activity. In other words, it includes all molecular events that tune the strength, duration, or specificity of RAR-mediated signal transduction, from ligand synthesis and receptor availability to cofactor recruitment and feedback loops.

Why Is regulation of retinoic acid receptor signaling pathway Important in Cell Biology?

Regulation of RAR signaling is essential for embryonic development, organogenesis, and adult tissue maintenance, and its disruption contributes to cancer, neurodevelopmental disorders, and metabolic diseases. Understanding GO:0048385 provides mechanistic insight into how cells interpret RA gradients and offers opportunities for targeted therapeutic intervention.
Controls anterior-posterior patterning and prefrontal connectivity in the developing brain.
Regulates neuropathic pain and comorbid anxiodepression via extracellular matrix homeostasis.
Essential for post-natal male germ cell differentiation and spermatogenesis.
Modulates myogenic differentiation and muscle regeneration.
Implicated in colorectal cancer progression and response to therapy.
Affects limbal epithelial cell behavior in aniridia models.
Evolutionarily conserved from invertebrates to vertebrates.
Regulates CD38 cell-surface antigen expression in hematopoietic cells.
Provides a paradigm for understanding nuclear receptor signaling regulation.
Offers targets for pharmacological modulation in disease.

What Happens During regulation of retinoic acid receptor signaling pathway?

Ligand availability and metabolism
In simple terms: The amount of retinoic acid available to bind receptors is controlled by enzymes that make or break it down.
Retinoic acid (RA) is synthesized from vitamin A (retinol) by retinaldehyde dehydrogenases and degraded by CYP26 enzymes. Regulation of RAR signaling begins with controlling RA levels, which determines receptor activation. In the prefrontal cortex, RA availability influences patterning and connectivity.
Receptor expression and isoform diversity
In simple terms: Different RAR and RXR subtypes can be produced in different tissues, changing how cells respond to RA.
RARs (alpha, beta, gamma) and RXRs (alpha, beta, gamma) are encoded by separate genes and exhibit tissue-specific expression. Their differential expression modulates signaling output and is a key regulatory node. For example, RAR alpha mediates CD38 induction in hematopoietic cells.
Cofactor recruitment and chromatin remodeling
In simple terms: Once RA binds, the receptors recruit helper proteins that open or close DNA, turning genes on or off.
Ligand-bound RAR-RXR heterodimers recruit coactivators (e.g., SRC-1, CBP) or corepressors (e.g., N-CoR, SMRT) to target gene promoters. This dynamic exchange regulates transcriptional output and is central to GO:0048385. In myogenic differentiation, selective RAR signaling modulates cofactor usage.
Post-translational modifications and feedback
In simple terms: Chemical tags added to receptors can change their activity, and the pathway can shut itself down.
Phosphorylation, ubiquitination, and sumoylation of RARs modulate their stability and activity. Negative feedback loops, including induction of CYP26, limit RA signaling duration. In colorectal cancer, such feedback influences tumor cell behavior.
Integration with other signaling pathways
In simple terms: RAR signaling talks to other communication lines in the cell, fine-tuning responses.
RAR signaling intersects with Wnt, FGF, and TGF-beta pathways, enabling context-dependent regulation. In neuropathic pain, cingulate RA signaling interacts with extracellular matrix homeostasis.

Key Genes Involved in GO:0048385 regulation of retinoic acid receptor signaling pathway

The following genes and proteins are central to the regulation of retinoic acid receptor signaling pathway (GO:0048385).
GeneMajor RoleResearch Relevance
RARARetinoic acid receptor alpha; mediates RA-induced differentiationImplicated in acute promyelocytic leukemia and CD38 induction
RARBRetinoic acid receptor beta; tumor suppressor-like functionsFrequently methylated in cancers; target for differentiation therapy
RARGRetinoic acid receptor gamma; skin and cartilage developmentStudied in myogenic differentiation
RXRARetinoid X receptor alpha; heterodimer partner for RARsEssential for RAR signaling; modulates metabolic gene expression
RXRBRetinoid X receptor beta; heterodimer partnerInvolved in developmental patterning
RXRGRetinoid X receptor gamma; tissue-specific functionsExpressed in brain and muscle; role in differentiation
ALDH1A1Retinaldehyde dehydrogenase; synthesizes retinoic acidRegulates RA levels in development and cancer
ALDH1A2Retinaldehyde dehydrogenase; RA synthesisCritical for embryonic patterning
ALDH1A3Retinaldehyde dehydrogenase; RA synthesisImplicated in neuropathic pain and cancer
CYP26A1Cytochrome P450; degrades retinoic acidFeedback regulator of RA signaling
CYP26B1Cytochrome P450; degrades retinoic acidControls RA gradients in germ cells
CYP26C1Cytochrome P450; degrades retinoic acidModulates RA levels in development
CRABP1Cellular retinoic acid-binding proteinBuffers intracellular RA; affects signaling intensity
CRABP2Cellular retinoic acid-binding proteinDelivers RA to RARs in nucleus
NCOR1Nuclear receptor corepressor 1Represses RAR target genes in absence of ligand
NCOA1Nuclear receptor coactivator 1 (SRC-1)Enhances RAR-mediated transcription
EP300Histone acetyltransferase p300Coactivator for RAR; chromatin remodeling

How Is regulation of retinoic acid receptor signaling pathway Regulated?

Regulation of RAR signaling is itself regulated by multiple mechanisms. Ligand availability is controlled by synthesis (ALDH1A1/2/3) and degradation (CYP26A1/B1/C1) enzymes. Receptor levels are modulated by transcriptional and post-transcriptional mechanisms, including microRNAs. Post-translational modifications such as phosphorylation and ubiquitination affect receptor stability and activity. Feedback loops, including RA-induced CYP26 expression, terminate signaling. Crosstalk with other pathways (e.g., MAPK, PI3K/AKT) further tunes RAR activity in a context-dependent manner.

regulation of retinoic acid receptor signaling pathway and Human Disease

GeneDisease / BiologyPotential Experimental Model
RARAAcute promyelocytic leukemia; differentiation blockKnockout and point-mutation cell lines (e.g., HL-60)
RARBColorectal cancer; tumor suppressionOverexpression and knockout in HCT116 cells
ALDH1A3Neuropathic pain; anxiodepressionKnockout mice and cingulate neuron cultures
CYP26B1Male infertility; germ cell differentiationKnockout and knock-in mouse models
RARGMyogenic differentiation defectsC2C12 myoblast knockout and overexpression
Cancer
Dysregulation of RAR signaling is a hallmark of several cancers. In colorectal cancer, altered RAR signaling contributes to tumor progression and is a target for differentiation therapy. RAR alpha is implicated in acute promyelocytic leukemia through PML-RARA fusions, and RAR beta is frequently silenced in solid tumors.
Neurodevelopmental and neurological disorders
Retinoic acid signaling regulates prefrontal patterning and connectivity; its disruption is linked to neurodevelopmental disorders. In neuropathic pain, cingulate RA signaling modulates comorbid anxiodepression via extracellular matrix homeostasis.
Reproductive disorders
RAR signaling is essential for post-natal male germ cell differentiation; its perturbation leads to impaired spermatogenesis and infertility.
Ocular and epithelial disorders
In aniridia limbal epithelial cell models, retinoic acid treatment alters the RA signaling pathway, suggesting a role in corneal epithelial homeostasis.

From regulation of retinoic acid receptor signaling pathway-Related Genes to Experimental Models

Research QuestionSuitable Model
Does loss of RAR alpha affect differentiation?RARA knockout cell line (e.g., HL-60)
How does a point mutation in RAR beta alter ligand binding?Point-mutation knock-in via CRISPR in cancer cells
What is the effect of RAR gamma overexpression on myogenesis?Overexpression in C2C12 myoblasts
How does RA signaling regulate germ cell differentiation?Knockout mouse models for CYP26B1
Can RAR signaling be modulated in limbal epithelial cells?siRNA-based knockdown in aniridia cell model
What genes are regulated by RAR in prefrontal cortex?Conditional knockout and RNA-seq in mouse brain

How to Study the regulation of retinoic acid receptor signaling pathway Process

MethodWhat It MeasuresTypical Application
RNA-seqGlobal gene expression changesIdentify RA-responsive genes
ChIP-seqRAR binding sites on chromatinMap RAR target promoters
ProteomicsProtein abundance and modificationsQuantify RAR cofactors
Reporter assaysTranscriptional activity of RARScreen for modulators
CRISPR screenLoss-of-function phenotypesDiscover regulators of RAR signaling
ImmunofluorescenceProtein localization and expressionValidate RAR expression in tissues
qPCRmRNA levels of target genesConfirm RA-induced transcription
Western blotProtein levels and phosphorylationAssess RAR stability
Transcriptomics (RNA-seq)
RNA sequencing measures global changes in gene expression upon modulation of RAR signaling. It is used to identify RA-responsive genes and regulatory networks.
Proteomics and interactomics
Mass spectrometry-based proteomics can quantify RAR and cofactor abundance, post-translational modifications, and protein-protein interactions.
Imaging and reporter assays
Fluorescent reporters and live-cell imaging visualize RAR signaling dynamics and subcellular localization in real time.
CRISPR screening
Genome-wide CRISPR knockout or activation screens identify regulators of RAR signaling and potential therapeutic targets.

How CRISPR Can Be Used to Study GO:0048385 regulation of retinoic acid receptor signaling pathway

Knockout

CRISPR knockout of RARs, RXRs, or metabolic enzymes (e.g., ALDH1A3, CYP26B1) creates loss-of-function models to study their roles in RAR signaling. For example, RARA knockout in HL-60 cells abolishes RA-induced CD38 expression.

Point Mutation

Point mutations in ligand-binding domains of RARs or in cofactor interaction interfaces can be introduced to dissect specific signaling outputs. Such models help distinguish between receptor subtypes.

Knock-in

Knock-in of tagged RARs (e.g., GFP or HA) allows visualization and purification of receptor complexes. Knock-in of disease-associated mutations (e.g., in RARB) models cancer predisposition.

Overexpression

Overexpression of RARs or coactivators (e.g., NCOA1) enhances signaling and can drive differentiation or transformation. This approach is used to study gain-of-function effects in myogenesis.

How EDITGENE Supports regulation of retinoic acid receptor signaling pathway Research

Researchers studying regulation of retinoic acid receptor signaling pathway-related genes often need to determine whether a candidate gene is causally involved in pathway regulation or disease. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for regulation of retinoic acid receptor signaling pathway research.

Frequently Asked Questions About regulation of retinoic acid receptor signaling pathway

GO:0048385 is the Gene Ontology term for regulation of retinoic acid receptor signaling pathway, defined as any process that modulates the frequency, rate or extent of RAR signaling activity.
Key genes include RARA, RARB, RARG, RXRA, RXRB, RXRG, ALDH1A1/2/3, CYP26A1/B1/C1, CRABP1/2, NCOR1, NCOA1, and EP300.
It is regulated by ligand availability, receptor expression, cofactor recruitment, post-translational modifications, and feedback loops.
Cancers (e.g., colorectal, leukemia), neuropathic pain, male infertility, and developmental disorders.
RNA-seq, ChIP-seq, proteomics, reporter assays, CRISPR screens, and imaging.
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect RAR signaling.
RAR alpha mediates retinoic acid-induced differentiation, including CD38 expression in hematopoietic cells.
Retinoic acid regulates prefrontal patterning and connectivity, influencing cognitive functions.
Cingulate retinoic acid signaling regulates neuropathic pain and comorbid anxiodepression via extracellular matrix homeostasis.
RAR signaling is essential for post-natal male germ cell differentiation; its disruption impairs spermatogenesis.

Conclusion

GO:0048385, regulation of retinoic acid receptor signaling pathway, is a critical biological process that integrates developmental and homeostatic cues. Its dysregulation underlies diverse pathologies, making it a prime target for therapeutic intervention. By leveraging CRISPR-based models and multi-omics approaches, researchers can dissect the complex regulatory networks controlling RAR signaling and accelerate the development of targeted therapies.

References

  1. 1. Shibata M et al.. 2021. Regulation of prefrontal patterning and connectivity by retinoic acid.. Nature 598(7881):483-488 PMID: 34599305
  2. 2. Li ZZ et al.. 2025. Cingulate retinoic acid signaling regulates neuropathic pain and comorbid anxiodepression via extracellular matrix homeostasis.. J Clin Invest 135(17) PMID: 40591414
  3. 3. Mark M et al.. 2015. Role of retinoic acid receptor (RAR) signaling in post-natal male germ cell differentiation.. Biochim Biophys Acta 1849(2):84-93 PMID: 24875094
  4. 4. Chen J et al.. 2016. Implication of retinoic acid receptor selective signaling in myogenic differentiation.. Sci Rep 6:18856 PMID: 26830006
  5. 5. Imajo M. 2019. Analysis of Retinoic Acid Receptor Signaling in Colorectal Cancer.. Methods Mol Biol 2019:85-93 PMID: 31359390
  6. 6. Hsu SL et al.. 2025. Effect of retinoic acid treatment on the retinoic acid signaling pathway in a human siRNA-based aniridia limbal epithelial cell model, in vitro.. PLoS One 20(6):e0324946 PMID: 40531840
  7. 7. Gutierrez-Mazariegos J et al.. 2014. Evolution of retinoic acid receptors and retinoic acid signaling.. Subcell Biochem 70:55-73 PMID: 24962881
  8. 8. Mehta K et al.. 1997. Involvement of retinoic acid receptor-alpha-mediated signaling pathway in induction of CD38 cell-surface antigen.. Blood 89(10):3607-14 PMID: 9160665
Contact Us
*
*
*
*
How did you hear about us: